Bio-Techne Declares $0.08 Quarterly Dividend, Conditional on Merck Deal
Bio-Techne plans a $0.08 per share dividend payable November 23, 2026, unless its pending Merck KGaA transaction closes by November 13, as reported by TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, which cites a PRNewswire release, Bio-Techne Corporation has declared a quarterly dividend of $0.08 per share for the three months that ended September 30, 2026.
The payment is scheduled for November 23, 2026, for holders of record at the close of business on November 13, 2026. The dividend will not be paid, however, if the previously announced transaction with Merck KGaA, Darmstadt, Germany closes on or before November 13.
The board will review any future cash dividends on a quarterly basis.
why it matters
The payout is small relative to the company's size, so the pending Merck KGaA deal is the main factor for investors. If it closes before the record date, the dividend will not be paid and attention will shift to the acquisition terms. The deal timeline will determine whether the payment goes out.
tags
instruments
sources
- BIO-TECHNE DECLARES DIVIDEND — TradingView, 4 November 2026 at 01:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗